Ribosomal protein L9 is a potential therapeutic target for B-ALL through the activation of the p53 signaling pathway - Li, Xinxin; Meng, Wenting; Wang, Xi; Huang, Siyong; Wang, Jianbin; Liang, Han; Si, Dailing (Frontiers in Immunology, 2025)